As the No Surprises Act (NSA) enters 2026, federal agencies are expected to focus on three key issues: finalizing delayed rulemaking, issuing guidance to address operational challenges in the Independent Dispute Resolution (IDR) process, and managing enforcement discretion amid ongoing litigation. At the same time, several statutory provisions remain unimplemented, creating regulatory uncertainty for health … Continue Reading
